Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza Vaccines
Preprint
Abstract
With the ever-present threat of pandemics, it is imperative we develop vaccine technologies eliciting broad and durable immunity to high-risk pathogens. Yet, current annual influenza vaccines, for example, fail to provide robust immunity against the 3-4 homologous strains they contain, let alone heterologous strains. Herein, we demonstrate that sustained delivery of multivalent influenza vaccines from an injectable polymer-nanoparticle (PNP) hydrogel technology induces more rapid, consistent, and potent humoral immune responses against multiple homologous viruses, as well as potent responses against heterologous viruses and potential pandemic subtypes H5N1, H7N9 and H9N2. Further, admixing PNP hydrogels with commercial influenza vaccines results in stronger hemagglutination inhibition against both heterologous and homologous viruses. We show this enhanced potency and breadth arises from higher affinity antibodies targeting both the hemagglutinin stem and head. Overall, this simple and effective sustained delivery platform for multivalent annual influenza vaccines generates durable, potent, and remarkably broad immunity to influenza.Keywords
All Related Versions
- Published version: Advanced Science, 12 (18), e2404498.
This publication has 69 references indexed in Scilit:
- Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS‐CoV‐2 Subunit VaccineAdvanced Healthcare Materials, 2023
- A Regimen Compression Strategy for Commercial Vaccines Leveraging an Injectable Hydrogel Depot Technology for Sustained Vaccine ExposureAdvanced Therapeutics, 2023
- Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist AntibodiesAdvanced Science, 2022
- Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of ageReviews in Medical Virology, 2022
- Gelation and yielding behavior of polymer–nanoparticle hydrogelsJournal of Polymer Science, 2021
- Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2Advanced Materials, 2021
- Modulation of injectable hydrogel properties for slow co‐delivery of influenza subunit vaccine components enhance the potency of humoral immunityJournal of Biomedical Materials Research Part A, 2021
- A Quantitative Description for Designing the Extrudability of Shear‐Thinning Physical HydrogelsMacromolecular Bioscience, 2020
- Leveraging the Modularity of Biomaterial Carriers to Tune Immune ResponsesAdvanced Functional Materials, 2020
- Injectable supramolecular polymer–nanoparticle hydrogels enhance human mesenchymal stem cell deliveryBioengineering & Translational Medicine, 2019